Evidence map›Paper›PMID 37846263›Full record

ReviewCureus2023

Digesting the Impact of Diet on Irritable Bowel Syndrome (IBS): Exploring Solutions for Controlling IBS.

Sai Suseel Sarvepalli, Shree Laya Vemula, Saikumar Aramadaka, Raam Mannam, Rajagopal Sankara Narayanan, Arpit Bansal, Vishnu R Yanamaladoddi

Open access · diamondAbstract readReview
In one paragraph

Review in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Observational
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Sai Suseel SarvepalliDepartment of Research, Narayana Medical College, Nellore, IND.
Shree Laya VemulaDepartment of Research, Anam Chenchu Subba Reddy (ACSR) Government Medical College, Nellore, IND.
Saikumar AramadakaDepartment of Internal Medicine, Narayana Medical College, Nellore, IND.
Raam MannamDepartment of General Surgery, Narayana Medical College, Nellore, IND.
Rajagopal Sankara NarayananDepartment of Research, Narayana Medical College, Nellore, IND.
Arpit BansalDepartment of Research, Narayana Medical College, Nellore, IND.
Vishnu R YanamaladoddiDepartment of General Surgery, Narayana Medical College and Hospital, Nellore, IND.
Government Vellore Medical College · INNarayan Medical College and Hospital · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Irritable bowel syndrome (IBS) plagues nearly a fifth of the general population. It is a chronic illness that can significantly lower quality of life (QoL) and work productivity. The relationship between diet and the functional gastrointestinal (GI) symptoms present in IBS is gaining more and more attention. In addition to being a factor in the pathophysiology of IBS, diet also has a significant impact on symptoms and overall well-being. Recent research has also shown that short-chain fermentable carbohydrates increase colonic gas production and small intestine water volume, which in turn causes functional GI symptoms in those with visceral hypersensitivity. This review article has consolidated various studies highlighting the association between certain foods and the pathophysiology of IBS. It has also talked about how restricting certain food items from the diet of affected individuals can relieve symptoms and in some cases can be more effective than pharmacotherapy. Although the low reduced fermentable oligosaccharide, disaccharide, monosaccharide, and polyol (FODMAP) diet (LFD) is a well-known method of treating IBS symptoms, over a third of individuals do not benefit from it. This article has also discussed the effectiveness and applicability of the LFD compared to other dietary therapies for the long-term management of IBS.

Indexed as

constipation-predominant ibs (ibs-c)diarrhea-predominant ibs (ibs-d)fodmap dietibsibs treatmenttreatment of ibs

Identifiers

PMID37846263
PMCPMC10576851
OpenAlexW4386783177

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.